Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2001
10/10/2001EP1139980A1 Cosmetic or medical preparation for topical use
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001EP1139754A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
10/10/2001EP1139752A1 Methods and compositions for treatment of cell proliferative disorders
10/10/2001EP1139750A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
10/10/2001EP1139744A1 Exo-r-mecamylamine formulation and use in treatment
10/10/2001EP1139743A1 Exo-s-mecamylamine formulation and use in treatment
10/10/2001EP1100512A4 Preparation of thioarabinofuranosyl compounds and use thereof
10/10/2001EP0830372B1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001CN1317047A GBS toxin receptor
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316431A Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application
10/10/2001CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative
10/10/2001CN1316273A Match of polyasparamide and paramagnetic metal and its preparing process and application
10/10/2001CN1316258A Natural drug fumigating liquid and its preparing process
10/10/2001CN1072679C Azasteroid compound, preparation and its use
10/10/2001CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines
10/10/2001CN1072650C Bibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agent
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/10/2001CN1072505C Novel antibody system for biological response modifiers
10/09/2001WO2000066625A1 Soybean protein nutraceuticals
10/09/2001US6300492 Nucleotide sequences for the prevention of suppression of apoptosis and treatment lymphoma, leukemia, melanoma, ovarian, mammary gland, pancreatic and lung cancers
10/09/2001US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers
10/09/2001US6300474 Modified interferons
10/09/2001US6300472 Rab proteins
10/09/2001US6300374 Applying the medicament comprising zinc salt of conjugated linoleic acid to a skin disorder, wherein the skin disorder is skin cancer
10/09/2001US6300345 Cyanoguanidines as cell proliferation inhibitors
10/09/2001US6300340 Useful for therapy of cancer and solid tumors
10/09/2001US6300338 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/09/2001US6300329 Heterocyclic pyrido(1,2-a)pyrazine compounds for treatment of parkinson's disease
10/09/2001US6300313 Means for treating prostate hypertrophy and prostate cancer
10/09/2001US6300059 Testing tissue sample to determime the expression levels of mrna or protein encoded by a p53 mediator, waf1, and compare values to normal tissue; diagnosis and therapy of human tumors, cancer therapy
10/09/2001US6299925 Effervescent green tea extract formulation
10/09/2001US6299897 Attaching selectin binding carbohydrate to a cross-linkable lipid; attaching an acidic group to a cross linkable lipid; forming lipids into sheet; crosslinking lipids
10/09/2001US6299877 Used in therapy
10/09/2001US6299876 Cytotoxic drug therapy
10/09/2001US6299869 Human interferon-epsilon: a type I interferon
10/09/2001CA2195844C Semi-synthetic taxanes with anti-tumoural activity
10/09/2001CA2123223C Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/09/2001CA2029787C Method for preparation of taxol using an oxazinone
10/07/2001CA2304906A1 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/07/2001CA2304869A1 Method of medical treatment using uric acid or precursors thereof
10/04/2001WO2001073439A1 Docosahexaenoic acid as retinoid x receptor and uses thereof
10/04/2001WO2001073133A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/04/2001WO2001073131A1 High specificity marker detection
10/04/2001WO2001073104A1 Beta-glucans from filamentous fungi
10/04/2001WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/04/2001WO2001073078A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
10/04/2001WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001WO2001072962A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072955A2 Regulation of human nedd1-related protein
10/04/2001WO2001072848A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
10/04/2001WO2001072840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072837A2 Methods of modulating drug clearance mechanisms by altering sxr activity
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072829A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
10/04/2001WO2001072826A2 Oncogenic osteomalacia-related gene 1
10/04/2001WO2001072823A1 Crystal structure of the (aml1 runt domain) / (cbfbeta) heterodimer and the ternary complex with dna
10/04/2001WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001WO2001072819A1 A new polypeptide- human gap connexin 9.35 and the polynucleotide encoding it
10/04/2001WO2001072818A1 A new polypeptide- human gap connexin 10 and the polynucleotide encoding it
10/04/2001WO2001072811A1 A new polypeptide-human s4 ribosomal protein 15 and the polynucleotide encoding it
10/04/2001WO2001072805A1 A new polypeptide - human flavoprotein subunit 14.19 and the polynucleotide encoding it
10/04/2001WO2001072804A1 A new polypeptide-human transducin 10 and the polynucleotide encoding it
10/04/2001WO2001072803A1 A new polypeptide- human zinc finger protein 15 and the polynucleotide encoding it
10/04/2001WO2001072802A1 A new polypeptide-human amyloid precursor protein-binding protein 14 and the polynucleotide encoding it
10/04/2001WO2001072800A1 A new polypeptide- human nuclear transforming protein 13 containing atp/gtp binding domain and the polynucleotide encoding it
10/04/2001WO2001072794A1 A novel polypeptide-helicase 16 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072793A1 A novel polypeptide-human proteolytic enzyme regulatory protein 12 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072788A1 A novel polypeptide-human pterin-molybdenum oxidoreductase 10 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072787A1 A novel polypeptide-human peroxidosome assembly factor 10 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072786A1 A novel polypeptide - tumor suppressor protein 63 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072785A1 A novel polypeptide-human helix-loop-helix protein 17 and the polynucleotide encoding said polypeptide
10/04/2001WO2001072784A2 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
10/04/2001WO2001072781A2 Human genes and expression products
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072779A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072775A2 Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
10/04/2001WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists
10/04/2001WO2001072765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
10/04/2001WO2001072744A1 N-heterocyclic derivatives as nos inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
1 ... 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 ... 2211